CENTURY ALUMINUM COMPANY (CENX)

US1564311082 - Common Stock

20.17  +0.86 (+4.45%)

Fundamental Rating

3

CENX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. CENX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CENX is not valued too expensively and it also shows a decent growth rate.



5

1. Profitability

1.1 Basic Checks

In the past year CENX was profitable.
CENX had a positive operating cash flow in the past year.
In the past 5 years CENX always reported negative net income.
Of the past 5 years CENX 4 years had a positive operating cash flow.

1.2 Ratios

CENX has a Return On Assets of 16.13%. This is amongst the best in the industry. CENX outperforms 95.92% of its industry peers.
CENX's Return On Equity of 46.91% is amongst the best of the industry. CENX outperforms 97.96% of its industry peers.
With a decent Return On Invested Capital value of 5.56%, CENX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CENX is significantly below the industry average of 8.76%.
The last Return On Invested Capital (5.56%) for CENX is above the 3 year average (2.82%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.13%
ROE 46.91%
ROIC 5.56%
ROA(3y)-4.65%
ROA(5y)-5.63%
ROE(3y)-18.45%
ROE(5y)-17.98%
ROIC(3y)2.82%
ROIC(5y)N/A

1.3 Margins

CENX's Profit Margin of 14.55% is amongst the best of the industry. CENX outperforms 86.39% of its industry peers.
CENX has a Operating Margin (4.80%) which is comparable to the rest of the industry.
CENX's Gross Margin of 7.52% is on the low side compared to the rest of the industry. CENX is outperformed by 62.59% of its industry peers.
Industry RankSector Rank
OM 4.8%
PM (TTM) 14.55%
GM 7.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CENX is destroying value.
The number of shares outstanding for CENX has been increased compared to 1 year ago.
CENX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CENX has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that CENX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.10, CENX is doing worse than 72.79% of the companies in the same industry.
CENX has a Debt/Equity ratio of 0.70. This is a neutral value indicating CENX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, CENX is not doing good in the industry: 84.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACC0.49
WACC11.41%

2.3 Liquidity

A Current Ratio of 1.71 indicates that CENX should not have too much problems paying its short term obligations.
CENX has a worse Current ratio (1.71) than 65.31% of its industry peers.
A Quick Ratio of 0.56 indicates that CENX may have some problems paying its short term obligations.
CENX has a Quick ratio of 0.56. This is amonst the worse of the industry: CENX underperforms 88.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.56

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 356.41% over the past year.
The Revenue has decreased by -4.60% in the past year.
Measured over the past years, CENX shows a small growth in Revenue. The Revenue has been growing by 2.91% on average per year.
EPS 1Y (TTM)356.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%584.62%
Revenue 1Y (TTM)-4.6%
Revenue growth 3Y10.83%
Revenue growth 5Y2.91%
Sales Q2Q%-1.12%

3.2 Future

CENX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.34% yearly.
The Revenue is expected to grow by 5.02% on average over the next years.
EPS Next Y242.19%
EPS Next 2Y140.99%
EPS Next 3Y40.34%
EPS Next 5YN/A
Revenue Next Year-1.46%
Revenue Next 2Y4.2%
Revenue Next 3Y5.02%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.17, CENX is valued on the expensive side.
67.35% of the companies in the same industry are more expensive than CENX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CENX to the average of the S&P500 Index (26.91), we can say CENX is valued slightly cheaper.
CENX is valuated reasonably with a Price/Forward Earnings ratio of 11.20.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CENX indicates a somewhat cheap valuation: CENX is cheaper than 70.75% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.26, CENX is valued rather cheaply.
Industry RankSector Rank
PE 20.17
Fwd PE 11.2

4.2 Price Multiples

CENX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CENX's earnings are expected to grow with 40.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y140.99%
EPS Next 3Y40.34%

0

5. Dividend

5.1 Amount

CENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (1/13/2025, 2:42:04 PM)

20.17

+0.86 (+4.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners61.9%
Inst Owner Change-0.02%
Ins Owners0.85%
Ins Owner Change0.51%
Market Cap1.87B
Analysts82.22
Price Target23.46 (16.31%)
Short Float %9.01%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.76%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)10.85%
Revenue beat(4)2
Avg Revenue beat(4)3.05%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)10.85%
Revenue beat(8)5
Avg Revenue beat(8)3.89%
Revenue beat(12)6
Avg Revenue beat(12)1.5%
Revenue beat(16)6
Avg Revenue beat(16)-0.21%
PT rev (1m)9.52%
PT rev (3m)24.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)223.08%
EPS NY rev (1m)4%
EPS NY rev (3m)52.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE 20.17
Fwd PE 11.2
P/S 0.89
P/FCF N/A
P/OCF 22.61
P/B 2.87
P/tB 2.87
EV/EBITDA 12.1
EPS(TTM)1
EY4.96%
EPS(NY)1.8
Fwd EY8.93%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.89
OCFY4.42%
SpS22.65
BVpS7.03
TBVpS7.03
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.13%
ROE 46.91%
ROCE 7.08%
ROIC 5.56%
ROICexc 5.69%
ROICexgc 5.69%
OM 4.8%
PM (TTM) 14.55%
GM 7.52%
FCFM N/A
ROA(3y)-4.65%
ROA(5y)-5.63%
ROE(3y)-18.45%
ROE(5y)-17.98%
ROIC(3y)2.82%
ROIC(5y)N/A
ROICexc(3y)2.95%
ROICexc(5y)N/A
ROICexgc(3y)2.95%
ROICexgc(5y)N/A
ROCE(3y)3.59%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA 2.47
Cap/Depr 120.43%
Cap/Sales 4.82%
Interest Coverage 2.88
Cash Conversion 44.76%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 0.56
Altman-Z 1.1
F-Score6
WACC11.41%
ROIC/WACC0.49
Cap/Depr(3y)115.08%
Cap/Depr(5y)86.6%
Cap/Sales(3y)3.74%
Cap/Sales(5y)3.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)356.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%584.62%
EPS Next Y242.19%
EPS Next 2Y140.99%
EPS Next 3Y40.34%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.6%
Revenue growth 3Y10.83%
Revenue growth 5Y2.91%
Sales Q2Q%-1.12%
Revenue Next Year-1.46%
Revenue Next 2Y4.2%
Revenue Next 3Y5.02%
Revenue Next 5YN/A
EBIT growth 1Y461.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year293.17%
EBIT Next 3Y56.32%
EBIT Next 5YN/A
FCF growth 1Y81.92%
FCF growth 3Y-28.91%
FCF growth 5YN/A
OCF growth 1Y1700%
OCF growth 3Y35.02%
OCF growth 5YN/A